|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Thermo Fisher Scientific Training
| | | Phone: | (760) 918-0135 | Year Established: | 1987 | Ticker: | TMO | Exchange: | NYSE | Main Contact: | Paul Grossman, Ph.D., Senior VP, Strategy and Corporate Development | | Other Contacts: | Paul R. Billings, MD, CMO John Cottingham, Chief Legal Officer Joe Beery, CIO David F. Hoffmeister, CFO Mark Stevenson, President & COO Gregory T. Lucier, Chairman & CEO
| | Company Description | Thermo Fisher Scientific, formerly Life Technologies Corp. and Microprobe) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses.
Life Technologies was created by the merger of Invitrogen Corporation and Applied Biosystems Inc, in November of 2008.
On Feb. 3, 2014, Thermo Fisher announced it has completed its acquisition of Life Technologies for $76.13 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. | |
|
|
|
|
|